CONCLUSIONS: Our findings reveal a novel mechanism wherein USP1 promotes Lenvatinib resistance in HCC by regulating chromosome alignment through PLK1 deubiquitination. The gene discussed is USP1; the disease is hepatocellular carcinoma.